fluorodeoxyglucose f18 has been researched along with Idiopathic Inflammatory Myopathies in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.38) | 18.2507 |
2000's | 9 (21.43) | 29.6817 |
2010's | 17 (40.48) | 24.3611 |
2020's | 15 (35.71) | 2.80 |
Authors | Studies |
---|---|
Agrawal, A; Purandare, N; Puranik, A; Rangarajan, V; Shah, S; Suthar, RR | 1 |
Beecher, G; Dubey, D; Ernste, F; Klein, CJ; Liewluck, T; Mandrekar, J; McKeon, A; Mills, JR; Milone, M; Naddaf, E; Pittock, SJ; Shelly, S; Triplett, J; Zekeridou, A | 1 |
Chen, D; Liang, J; Lin, J; Liu, Y; Su, X; Wang, G; Wang, H; Yan, J; Zhao, K; Zhao, X | 1 |
Emmungil, H; İlgen, U | 1 |
Albayda, J; Carlier, PG; Demonceau, G | 1 |
Bailly, M; Besse, H; Callaud, A; Metrard, G; Thibault, F | 1 |
Aslan, B; Dilbil, M; Erbasan, F; Nokay, M; Öğüt, TS; Terzioğlu, ME; Yazısız, V | 1 |
Bentick, G; Day, J; Fairley, J; Nadesapillai, S; Wicks, I | 1 |
Al-Zaghal, A; Alavi, A; Debs, P; Solnes, LB | 1 |
Aigner, RM; Gstettner, C; Nazerani-Zemann, T; Pernthaler, B; Stanzel, S | 1 |
Jabbar, PK; Karthik, V; Nair, A; Roshan, R | 1 |
Humbert, O; Levraut, M; Lidove, O; Martis, N | 1 |
Blondet, C; Geny, B; Matuszak, J; Meyer, A; Namer, IJ | 1 |
Koizumi, M; Koyama, M; Sugiura, Y; Terauchi, T | 1 |
Cantarini, L; Conticini, E; Frediani, B; Selvi, E | 1 |
Bouchard, M; Lemay, J; Rousseau, É | 1 |
Creytens, D; Kruse, V; Ost, P; Spaas, M; Van den Broeck, B | 1 |
Cao, H; He, Y; Ke, Y; Liang, J; Lin, J; Liu, Y; Sun, Y; Xu, B; Ye, B | 1 |
Okada, M; Rokutanda, R; Tomishima, Y | 1 |
Abulizi, M; Aoun-Sebaiti, M; Authier, FJ; Blanc-Durand, P; Guedj, E; Itti, E; Lerman, L; Van Der Gucht, A; Verger, A | 1 |
Abulizi, M; Aoun-Sebaiti, M; Authier, FJ; Blanc-Durand, P; Emsen, B; Gherardi, RK; Itti, E; Van Der Gucht, A; Verger, A | 1 |
Besson, FL; Durand, E; Labeyrie, C; Lerolle, N; Pelissou, C | 1 |
Bai, Y; Dong, A; Wang, Y | 1 |
Chen, SJ; Guan, YH; Hua, FC; Wang, XY | 1 |
Judson, MA; Kalkanis, AG; Kalkanis, DG; Polychronopoulos, VS | 1 |
Becker, S; Bedat-Millet, AL; Marie, I; Sauvêtre, G | 1 |
Agnew, J; Bennett, O; Ravi Kumar, AS | 1 |
Abulizi, M; Aouizerate, J; Aoun Sebaiti, M; Authier, FJ; Bachoud-Levi, AC; Chalaye, J; Cottereau, AS; Evangelista, E; Gherardi, RK; Guedj, E; Itti, E; Van Der Gucht, A; Verger, A; Yara, S | 1 |
Abela, GS; Berger, K; Durga, S; Janoudi, A; Pervaiz, MH | 1 |
Abulizi, M; Authier, FJ; Blanc-Durand, P; Itti, E; Sebaiti, MA; Van Der Gucht, A | 1 |
Hayashi, Y; Hosoe, H; Hozumi, I; Ikeda, T; Inuzuka, T; Kimura, A; Matsuyama, Z; Sakurai, T; Suzuki, Y; Takahashi, H; Tanaka, Y | 1 |
Al-Nahhas, A; Harari, OA; Jawad, A | 1 |
Kalra, S; Loe, MJ; Mullan, BP; Subramaniam, RM; Tiegs, RD; Utz, JP | 1 |
Hayashi, K; Kita, T; Kosuda, S; Tomita, H | 1 |
Gan, M; Luo, L; Tang, G; Tang, X; Wang, M | 1 |
Ametamey, SM; Bode, B; Buck, A; Honer, M; Kaim, AH; Späth, N; Weber, B; Westera, G; Wyss, MT | 1 |
Ametamey, SM; Buck, A; Gottschalk, J; Honer, M; Kaim, AH; Späth, N; von Schulthess, GK; Weber, B; Wyss, MT | 1 |
Strobel, K; Stumpe, KD | 1 |
Billotey, C; Bouhour, F; Broussolle, C; Dufour, JF; Sève, P; Streichenberger, N | 1 |
Gysen, M; Mortelmans, L; Stroobants, S | 1 |
Buck, A; Gottschalk, J; Kaim, AH; Kurrer, MO; Schweitzer, A; von Schulthess, GK; Weber, B; Westera, G | 1 |
Aigner, RM; Schwarz, T; Wolf, G | 1 |
5 review(s) available for fluorodeoxyglucose f18 and Idiopathic Inflammatory Myopathies
Article | Year |
---|---|
Muscle imaging in myositis: MRI, US, and PET.
Topics: Biomarkers; Edema; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Muscle, Skeletal; Myositis; Myositis, Inclusion Body; Positron-Emission Tomography; Water | 2022 |
Pneumomediastinum, pneumatosis intestinalis and pneumoperitoneum in a patient with polymyositis: case-based review.
Topics: Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Mediastinal Emphysema; Middle Aged; Myositis; Pneumatosis Cystoides Intestinalis; Pneumoperitoneum; Polymyositis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Remission, Spontaneous | 2023 |
Defining the clinical utility of PET or PET-CT in idiopathic inflammatory myopathies: A systematic literature review.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Inflammation; Myositis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Sarcopenia and Myositis Revisited: Emerging Role of Fluorine-18 Fluorodeoxyglucose PET in Muscle Imaging.
Topics: Fluorodeoxyglucose F18; Humans; Muscle, Skeletal; Myositis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcopenia | 2023 |
18F FDG-PET imaging in musculoskeletal infection.
Topics: Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Image Enhancement; Myositis; Osteitis; Osteomyelitis; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
37 other study(ies) available for fluorodeoxyglucose f18 and Idiopathic Inflammatory Myopathies
Article | Year |
---|---|
Sunitinib-Induced Myositis Detected on 18F-FDG PET/CT.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Myositis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sunitinib | 2022 |
Cancer and immune-mediated necrotizing myopathy: a longitudinal referral case-controlled outcomes evaluation.
Topics: Autoantibodies; Autoimmune Diseases; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Muscle, Skeletal; Muscular Diseases; Myositis; Necrosis; Neoplasms; Positron Emission Tomography Computed Tomography | 2022 |
Elevated spleen FDG uptake predicts unfavorable outcome in adult idiopathic-inflammatory-myopathy patients: a crisis beyond muscles.
Topics: Adult; Autoimmune Diseases; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Muscles; Myositis; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Spleen | 2022 |
Imaging in myositis: MRI or
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Myositis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
18 F-FDG Muscular Uptake in Statin-Associated Symptoms Without Myositis : How Long to Stop Treatment for Image Quality Improvement?
Topics: Aged, 80 and over; Creatine Kinase; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Muscular Diseases; Myositis; Quality Improvement | 2022 |
F18-FDG PET/CT in a patient with Antisynthetase Syndrome.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Myositis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2023 |
Isolated muscular sarcoidosis presenting as hypercalcaemic renal failure.
Topics: Fluorodeoxyglucose F18; Granuloma; Humans; Hypercalcemia; Male; Myositis; Renal Insufficiency; Sarcoidosis | 2023 |
Comment on: Muscle fluorodeoxyglucose uptake assessed by positron emission tomography-computed tomography as a biomarker of inflammatory myopathies disease activity.
Topics: Biomarkers; Fluorodeoxyglucose F18; Humans; Myositis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2019 |
Comment on: Muscle fluorodeoxyglucose uptake assessed by positron emission tomography-computed tomography as a biomarker of inflammatory myopathies disease activity: reply.
Topics: Biomarkers; Fluorodeoxyglucose F18; Humans; Myositis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2019 |
Granulomatous Myositis Showing Fluctuating "Leopard-Man" Sign: A Case Report on FDG PET/CT Imaging.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Middle Aged; Myositis; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2019 |
Comment on: Muscle fluorodeoxyglucose uptake assessed by positron emission tomography-computed tomography as a biomarker of inflammatory myopathies disease activity.
Topics: Biomarkers; Fluorodeoxyglucose F18; Humans; Muscles; Myositis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2021 |
Radiation Recall Myositis Detected With 18F-FDG PET/CT After a Treatment of Cervical Cancer.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Myositis; Positron Emission Tomography Computed Tomography; Radiation Injuries; Treatment Outcome; Uterine Cervical Neoplasms | 2020 |
Spatiotemporal Evolution of Radiation Myositis on 18F-FDG PET/CT Following Hypofractionated Radiotherapy of Intramuscular Melanoma Metastases.
Topics: Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Melanoma; Middle Aged; Myositis; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiation Dose Hypofractionation; Radiation Injuries | 2021 |
The lungs were on fire: a pilot study of
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases, Interstitial; Myositis; Pilot Projects; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2021 |
Sarcoid Myofasciitis.
Topics: Adrenal Cortex Hormones; Fasciitis; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Muscle, Skeletal; Myositis; Positron-Emission Tomography; Quadriceps Muscle; Radiopharmaceuticals; Sarcoidosis; Sarcoidosis, Pulmonary | 2017 |
Cerebral 18F-FDG PET in macrophagic myofasciitis: An individual SVM-based approach.
Topics: Adult; Algorithms; Brain; Fasciitis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myositis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Support Vector Machine | 2017 |
Predictive value of brain 18F-FDG PET/CT in macrophagic myofasciitis?: A case report.
Topics: Brain Diseases; Fasciitis; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Myositis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2017 |
18F-FDG PET/CT and MRI in Necrotizing Autoimmune Myopathy: "The Scarface Sign".
Topics: Autoimmune Diseases; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myositis; Necrosis; Positron Emission Tomography Computed Tomography | 2018 |
Focal Myositis of the Leg Presenting as Fever of Unknown Origin Detected by FDG PET/CT.
Topics: Adult; Diagnosis, Differential; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Male; Myositis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Detection of multiple muscle involvement in eosinophilic myositis with ¹⁸F-FDG PET/CT.
Topics: Adult; Eosinophilia; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Muscle, Skeletal; Muscular Dystrophies, Limb-Girdle; Myositis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Detection of sarcoidosis associated fasciitis by uptake on a FDG PET scan: a novel finding.
Topics: Animals; Fasciitis; Fluorodeoxyglucose F18; Humans; Myositis; Positron-Emission Tomography; Sarcoidosis | 2013 |
Clinical images: Focal myositis demonstrated on positron emission tomography.
Topics: Adult; Biopsy; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Muscle, Skeletal; Myositis; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Focal Inflammatory Myositis on 18F-FDG PET/CT.
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Myositis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoma | 2016 |
Brain
Topics: Adolescent; Adult; Aged; Brain; Brain Diseases, Metabolic; Chronic Disease; Cognition Disorders; Fasciitis; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Myositis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2017 |
PET/CTA detection of muscle inflammation related to cholesterol crystal emboli without arterial obstruction.
Topics: Animals; Arteries; Biomarkers; Cholesterol; Computed Tomography Angiography; Crystallization; Fluorodeoxyglucose F18; Inflammation; Injections, Intra-Arterial; Microspheres; Muscle, Skeletal; Myositis; Necrosis; Plaque, Atherosclerotic; Polystyrenes; Positron-Emission Tomography; Rabbits; Thrombosis | 2018 |
Brain
Topics: Brain; Fasciitis; Fluorodeoxyglucose F18; Humans; Myositis | 2017 |
Selective cauda equina hypertrophy with idiopathic inflammation.
Topics: Adult; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Myositis; Polyradiculopathy; Positron-Emission Tomography | 2008 |
18F-fluorodeoxyglucose-positron emission tomography imaging in idiopathic inflammatory myositis.
Topics: Aged; Biopsy; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Myositis; Necrosis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2008 |
Interesting image. F-18 fluorodeoxyglocose positron emission tomography/computed tomography in the diagnosis of chronic myopathic sarcoidosis.
Topics: Aged; Chronic Disease; Female; Fluorodeoxyglucose F18; Humans; Myositis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2010 |
Radiation-induced myositis mimicking chest wall tumor invasion in two patients with lung cancer: a PET/CT study.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Myositis; Neoplasm Invasiveness; Positron-Emission Tomography; Radiation Injuries; Thoracic Wall; Tomography, X-Ray Computed | 2012 |
Synthesis and evaluation of O-(3-[18F]fluoropropyl)-L-tyrosine as an oncologic PET tracer.
Topics: Animals; Fibrosarcoma; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Isotope Labeling; Mice; Myositis; Organ Specificity; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed; Tyrosine | 2003 |
18F-choline in experimental soft tissue infection assessed with autoradiography and high-resolution PET.
Topics: Animals; Autoradiography; Choline; Fluorodeoxyglucose F18; Metabolic Clearance Rate; Muscle, Skeletal; Myositis; Neoplasms; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Soft Tissue Infections; Staphylococcal Infections; Tissue Distribution | 2004 |
Influence of ceftriaxone treatment on FDG uptake--an in vivo [18F]-fluorodeoxyglucose imaging study in soft tissue infections in rats.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Fluorodeoxyglucose F18; Male; Metabolic Clearance Rate; Myositis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Soft Tissue Infections; Staphylococcal Infections; Treatment Outcome | 2004 |
[Sarcoidosis demonstrated by fluorodeoxyglucose positron emission tomography in a case of granulomatous myopathy].
Topics: Fluorodeoxyglucose F18; Granuloma; Humans; Male; Middle Aged; Myositis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Whole Body Imaging | 2007 |
Proliferative myositis: a case of a pseudomalignant process.
Topics: Adolescent; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Muscle Neoplasms; Myositis; Psoas Muscles; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, Emission-Computed | 1998 |
(18)F-FDG and (18)F-FET uptake in experimental soft tissue infection.
Topics: Abscess; Animals; Autoradiography; Carbon Radioisotopes; Deoxyglucose; Fluorodeoxyglucose F18; Leg; Leukocytes; Myositis; Radionuclide Imaging; Radiopharmaceuticals; Rats; Reference Values; Staphylococcal Infections; Tyrosine | 2002 |
Pathologic uptake in F-18 FDG positron emission tomography of the residuals of a surgically removed needle abscess.
Topics: Abscess; Aged; Buttocks; Female; Fluorodeoxyglucose F18; Humans; Muscle, Skeletal; Myositis; Needles; Postoperative Period; Radionuclide Imaging; Radiopharmaceuticals | 2002 |